Overview
Seiji Shirakawa practices practicing medicine in Nagasaki, Japan.
His clinical expertise encompasses Squamous Cell Carcinoma of the Anal Canal (SCAC).
He is actively involved in clinical research, co-authoring 35 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Seiji Shirakawa
Is Seiji Shirakawa a top-rated expert for Squamous Cell Carcinoma of the Anal Canal (SCAC)?
MediFind is an objective health platform that identifies experts based on real-world data. Seiji Shirakawa is classified as an Experienced expert for Squamous Cell Carcinoma of the Anal Canal (SCAC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Seiji Shirakawa participate in research or clinical trials?
Yes. Seiji Shirakawa has published 35 articles and abstracts on conditions like Squamous Cell Carcinoma of the Anal Canal (SCAC). You can view a list of Seiji Shirakawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Squamous Cell Carcinoma of the Anal Canal (SCAC)